Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
- 7 July 2020
- journal article
- letter
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 76 (1), 122-124
- https://doi.org/10.1016/j.jacc.2020.05.001
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19The New England Journal of Medicine, 2020
- Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2Journal of Thrombosis and Thrombolysis, 2020
- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis, 2020
- Disseminated intravascular coagulation in patients with 2019‐nCoV pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020